` 6618 (JD Health International Inc) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

6618
vs
Hang Seng (Hong Kong)

Over the past 12 months, has underperformed Hang Seng (Hong Kong), delivering a return of -14% compared to the Hang Seng (Hong Kong)'s 19% growth.

Stocks Performance
6618 vs Hang Seng (Hong Kong)

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
6618 vs Hang Seng (Hong Kong)

Loading
6618
Hang Seng (Hong Kong)
Difference

Performance By Year
6618 vs Hang Seng (Hong Kong)

Loading
6618
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
JD Health International Inc vs Peers

Hang Seng (Hong Kong)
6618
AMZN
BABA
PDD
3690
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

JD Health International Inc
Glance View

Market Cap
88.9B HKD
Industry
Retail

JD Health International Inc., a significant arm of the Chinese e-commerce giant JD.com, emerges as a leading force in the digital healthcare landscape. It operates by seamlessly blending technology with healthcare services, providing a multitude of solutions designed to cater to the diverse needs of its users. They have harnessed the power of the internet to offer online medical consultations, a service that connects patients with a network of licensed healthcare professionals. This innovative approach not only broadens access to medical advice and care but also disrupts traditional healthcare models by emphasizing convenience and accessibility. By utilizing advanced algorithms and AI technology, JD Health also offers personalized health management, positioning itself as a pivotal participant in the quest for enriched digital health experiences. The revenue model of JD Health is underpinned by its multifaceted ecosystem, primarily driven by the sale of pharmaceutical products, healthcare merchandise, and the provision of online medical services. They employ a B2C strategy that accounts for most of their sales, utilizing JD.com’s expansive logistics network to ensure swift and reliable delivery. Additionally, the company monetizes its platform by offering premium health-related content and services on a subscription basis, appealing to a broad audience eager to embrace new healthcare paradigms. As the digital transformation of healthcare accelerates, JD Health strategically positions itself to benefit from an expanding market, leveraging its technological expertise and comprehensive service offerings to make healthcare more accessible and efficient for its growing user base.

Intrinsic Value
34.58 HKD
Undervaluation 19%
Intrinsic Value
Price
Back to Top